Search research articles
Contact Us
Filters
Showing results (31-40 of 143) with videos related to
Page
of 15
Sort By:
Fundamental & Clinical Pharmacology
|
January 1, 1993
Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotension
J M Senard, O Rascol, A Rascol, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1992
A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease
J L Montastruc, O Rascol, J M Senard, et al.
Thrombosis Et Diathesis Haemorrhagica
|
September 30, 1975
Proceedings: Prevention of ischemic cerebro vascular accident: a long term clinical trial with vasodilator and antiaggregating drugs
B Guiraud, J David, G Géraud, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1994
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up
J L Montastruc, O Rascol, J M Senard, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
April 1, 1992
Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension
J M Senard, B Chamontin, A Rascol, et al.
Advances in Neurology
|
January 1, 1996
Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences
J L Montastruc, J M Senard, O Rascol, et al.
Pathologie-Biologie
|
December 1, 1972
[Renewal of platelets and duration of inhibition of the second aggregation wave after a single dose of aspirin]
B Boneu, R Bierme, A Boneu, et al.
Annales Medico-Psychologiques
|
July 1, 1984
[Psychotic manifestations in myasthenia gravis]
L Schmitt, P Arrue, M Escande, et al.
Stroke
|
January 1, 1982
Pure motor hemiplegia: CT study of 30 cases
A Rascol, M Clanet, C Manelfe, et al.
Clinical Neuropharmacology
|
January 1, 1986
Mesulergine (CU 32-085) in the treatment of Parkinson's disease
A Rascol, J L Montastruc, O Rascol, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 143) with videos related to
Sort By:
Page
of 15
Fundamental & Clinical Pharmacology
|
January 1, 1993
Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotension
J M Senard, O Rascol, A Rascol, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1992
A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease
J L Montastruc, O Rascol, J M Senard, et al.
Thrombosis Et Diathesis Haemorrhagica
|
September 30, 1975
Proceedings: Prevention of ischemic cerebro vascular accident: a long term clinical trial with vasodilator and antiaggregating drugs
B Guiraud, J David, G Géraud, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1994
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up
J L Montastruc, O Rascol, J M Senard, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
April 1, 1992
Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension
J M Senard, B Chamontin, A Rascol, et al.
Advances in Neurology
|
January 1, 1996
Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences
J L Montastruc, J M Senard, O Rascol, et al.
Pathologie-Biologie
|
December 1, 1972
[Renewal of platelets and duration of inhibition of the second aggregation wave after a single dose of aspirin]
B Boneu, R Bierme, A Boneu, et al.
Annales Medico-Psychologiques
|
July 1, 1984
[Psychotic manifestations in myasthenia gravis]
L Schmitt, P Arrue, M Escande, et al.
Stroke
|
January 1, 1982
Pure motor hemiplegia: CT study of 30 cases
A Rascol, M Clanet, C Manelfe, et al.
Clinical Neuropharmacology
|
January 1, 1986
Mesulergine (CU 32-085) in the treatment of Parkinson's disease
A Rascol, J L Montastruc, O Rascol, et al.
Page
of 15